Literature DB >> 20040758

Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Dennis Adeegbe1, Robert B Levy, Thomas R Malek.   

Abstract

T regulatory cells (Tregs) represent agents to mediate tolerance to allografts so that the use of immunosuppressive drugs is avoided. In this regard, we previously demonstrated that the adoptive transfer of allogeneic Tregs into IL-2Rbeta(-/-) mice prevented autoimmunity and led to allograft tolerance. Here, we investigated the requirements and mechanisms that favor this long-lasting tolerance. The most potent tolerance required exact matching of all alloantigens between the adoptively transferred allogeneic Tregs and allogeneic skin grafts, but tolerance to such allografts that lacked expression of major histocompatibility complex class I or II molecules also occurred. Thus, Tregs are not required to directly recognize major histocompatibility complex class II alloantigens to suppress skin transplant rejection. Depletion of allogeneic Tregs substantially, but not completely, abrogated this form of tolerance. However, thymocytes from allogeneic Treg adoptively transferred IL-2Rbeta(-/-) mice did not reject the corresponding allogeneic skin graft in secondary Scid recipients. Consistent with a requirement for a deletional mechanism in this IL-2Rbeta(-/-) model, a small number of wild-type T cells readily abrogated the immune tolerant state. Collectively, these findings indicate that full tolerance induction is largely dependent on substantial Treg-mediated suppression and thymic deletion of alloreactive T cells and may represent general conditions for Treg-mediated transplantation tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040758      PMCID: PMC2837323          DOI: 10.1182/blood-2009-08-238584

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.

Authors:  Cherry I Kingsley; Mahzuz Karim; Andrew R Bushell; Kathryn J Wood
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.

Authors:  M Wolf; A Schimpl; T Hünig
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

3.  Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.

Authors:  T R Malek; A Yu; P Scibelli; M G Lichtenheld; E K Codias
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 4.  NK cells and transplantation.

Authors:  Christine L Hsieh; Hideaki Obara; Yasuhiro Ogura; Olivia M Martinez; Sheri M Krams
Journal:  Transpl Immunol       Date:  2002-05       Impact factor: 1.708

5.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

Review 6.  Human T regulatory cell therapy: take a billion or so and call me in the morning.

Authors:  James L Riley; Carl H June; Bruce R Blazar
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

7.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.

Authors:  Thomas R Malek; Aixin Yu; Vladimir Vincek; Paul Scibelli; Lin Kong
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

8.  Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus.

Authors:  JiChu Li; JooHung Park; Deborah Foss; Irving Goldschneider
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

9.  Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Petra Hoffmann; Joerg Ermann; Matthias Edinger; C Garrison Fathman; Samuel Strober
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

10.  CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Authors:  José L Cohen; Aurélie Trenado; Douglas Vasey; David Klatzmann; Benoît L Salomon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  12 in total

1.  Nanowire substrate-based laser scanning cytometry for quantitation of circulating tumor cells.

Authors:  Sang-Kwon Lee; Gil-Sung Kim; Yu Wu; Dong-Joo Kim; Yao Lu; Minsuk Kwak; Lin Han; Jung-Hwan Hyung; Jin-Kyeong Seol; Chantal Sander; Anjelica Gonzalez; Jie Li; Rong Fan
Journal:  Nano Lett       Date:  2012-05-31       Impact factor: 11.189

2.  The Lower Limit of Regulatory CD4+ Foxp3+ TCRβ Repertoire Diversity Required To Control Autoimmunity.

Authors:  Aixin Yu; Michael J Dee; Dennis Adeegbe; Connor J Dwyer; Norman H Altman; Thomas R Malek
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

Review 3.  Role of immune-regulatory cells in skin pathology.

Authors:  Dan Ilkovitch
Journal:  J Leukoc Biol       Date:  2010-07-13       Impact factor: 4.962

4.  Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yanqing Bian; Baohua Zhao; Yuzhang Wu; Jianxun Song
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

5.  Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure.

Authors:  B E Burrell; J S Bromberg
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

Review 6.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

7.  Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.

Authors:  Hong Xu; Deborah M Ramsey; Shengli Wu; Larry D Bozulic; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

8.  Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.

Authors:  Eun-Sol Lee; Jung-Yeon Lim; Keon-Il Im; Nayoun Kim; Young-Sun Nam; Young-Woo Jeon; Seok-Goo Cho
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

9.  Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.

Authors:  Veena Kochat; Sumod Kanjirakkuzhiyil; Prakash Baligar; Perumal Nagarajan; Asok Mukhopadhyay
Journal:  Stem Cell Res Ther       Date:  2015-07-08       Impact factor: 6.832

10.  The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.

Authors:  Jung Ho Lee; Eun-Joo Jeon; Nayoun Kim; Young-Sun Nam; Keon-Il Im; Jung-Yeon Lim; Eun-Jung Kim; Mi-La Cho; Ki Taik Han; Seok-Goo Cho
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.